Find, compare & contact
Metyrapone API Manufacturers & Suppliers

Looking for Metyrapone API 54-36-4?

Description:

Here you will find a list of producers, manufacturers and distributors of Metyrapone. You can filter on certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.

API | Excipient name:

Metyrapone 

Synonyms:

Metirapona , Metopiron , Metopirone , Metyrapone , Metyraponum  

Cas Number:

54-36-4 

DrugBank number:

DB01011 

Unique Ingredient Identifier:

ZS9KD92H6V

Metyrapone is a type of Adrenal steroid inhibitors

Adrenal steroid inhibitors belong to the subcategory of pharmaceutical active pharmaceutical ingredients (APIs) used in the field of medicine. These inhibitors specifically target and modulate the production or activity of adrenal steroids, which are hormones produced by the adrenal glands.

Adrenal steroid inhibitors play a crucial role in the treatment of various medical conditions, including hormonal imbalances, inflammatory disorders, and certain types of cancer. By inhibiting the synthesis or action of adrenal steroids, these APIs help regulate hormone levels and alleviate associated symptoms.

One commonly used adrenal steroid inhibitor is ketoconazole. This API inhibits the enzyme responsible for converting cholesterol into adrenal steroids, thereby reducing their production. Another example is spironolactone, which blocks the action of aldosterone, a steroid hormone that regulates salt and water balance in the body.

The pharmaceutical industry relies on the development and manufacturing of high-quality adrenal steroid inhibitors to meet the growing demand for effective treatments. Through rigorous research, scientists are continually exploring new compounds and formulations to enhance the efficacy and safety of these APIs.

In conclusion, adrenal steroid inhibitors are a vital subcategory of pharmaceutical APIs that have significant therapeutic implications. Their ability to modulate adrenal steroid production or activity makes them indispensable in treating various medical conditions. Continued advancements in this field will undoubtedly lead to the development of improved therapies and better patient outcomes.

Metyrapone (Adrenal steroid inhibitors), classified under Others

The others category refers to pharmaceutical APIs that do not fall under specific classifications such as antibiotics, antivirals, analgesics, or cardiovascular drugs. These APIs are diverse in nature and serve various therapeutic purposes, making them a crucial component of pharmaceutical formulations.

Pharmaceutical companies develop APIs in the others category to address specific medical conditions or target novel biological pathways. This category includes APIs used in oncology, neurology, immunology, and other specialized areas of medicine. The APIs in this category are often designed to interact with specific molecular targets or receptors, providing targeted therapeutic effects.

The development of APIs in the others category requires extensive research and testing to ensure their efficacy, safety, and compliance with regulatory standards. Pharmaceutical manufacturers employ advanced techniques such as chemical synthesis, biotechnology, and genetic engineering to produce these APIs.

Due to the broad range of applications and therapeutic uses, APIs in the others category contribute significantly to the advancement of medical treatments. Pharmaceutical companies constantly strive to innovate and discover new APIs within this category to address unmet medical needs and improve patient outcomes.

In conclusion, the others category of pharmaceutical APIs encompasses a diverse range of active ingredients used in drug formulation. These APIs play a crucial role in developing innovative therapies across various therapeutic areas, contributing to advancements in healthcare and patient well-being.